Medical Care
Global Flow Cytometry in Oncology Market Research Report 2025
- Jul 08, 25
- ID: 348519
- Pages: 89
- Figures: 88
- Views: 11
The global market for Flow Cytometry in Oncology was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Among the clinical uses of flow cytometry cancer represents one of the most relevant. Several applications of flow cytometry can currently be applied to the study of cancer, including the detection of tumour cell DNA aneuploidy, the analysis of tumour cell proliferation and the immunophenotyping of leukemias.
North American market for Flow Cytometry in Oncology is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Flow Cytometry in Oncology is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Flow Cytometry in Oncology in Diagnostic Laboratories is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Flow Cytometry in Oncology include Agilent Technologies, Inc., Apogee Flow Systems Ltd., Becton, Dickinson and Company, bioAffinity Technologies, Inc., Bio-Rad Laboratories, Inc., Bio-Techne Corporation Cytek Biosciences, Cytognos, S.L., Danaher Corporation, Miltenyi Biotec B.V. and Co. KG, Laboratory Corporation of America Holdings, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Flow Cytometry in Oncology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Flow Cytometry in Oncology.
The Flow Cytometry in Oncology market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Flow Cytometry in Oncology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Flow Cytometry in Oncology companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Agilent Technologies, Inc.
Apogee Flow Systems Ltd.
Becton, Dickinson and Company
bioAffinity Technologies, Inc.
Bio-Rad Laboratories, Inc.
Bio-Techne Corporation Cytek Biosciences
Cytognos, S.L.
Danaher Corporation
Miltenyi Biotec B.V. and Co. KG
Laboratory Corporation of America Holdings
Luminex Corporation
NeoGenomics Laboratories, Inc.
Sony Corporation
Thermo Fisher Scientific Inc
Segment by Type
Assays and Kits
Instruments
Reagents and Consumables
Software
Segment by Application
Diagnostic Laboratories
Hospitals and Healthcare Centers
Academic and Research Institutions
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Flow Cytometry in Oncology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Among the clinical uses of flow cytometry cancer represents one of the most relevant. Several applications of flow cytometry can currently be applied to the study of cancer, including the detection of tumour cell DNA aneuploidy, the analysis of tumour cell proliferation and the immunophenotyping of leukemias.
North American market for Flow Cytometry in Oncology is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Flow Cytometry in Oncology is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Flow Cytometry in Oncology in Diagnostic Laboratories is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Flow Cytometry in Oncology include Agilent Technologies, Inc., Apogee Flow Systems Ltd., Becton, Dickinson and Company, bioAffinity Technologies, Inc., Bio-Rad Laboratories, Inc., Bio-Techne Corporation Cytek Biosciences, Cytognos, S.L., Danaher Corporation, Miltenyi Biotec B.V. and Co. KG, Laboratory Corporation of America Holdings, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Flow Cytometry in Oncology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Flow Cytometry in Oncology.
The Flow Cytometry in Oncology market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Flow Cytometry in Oncology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Flow Cytometry in Oncology companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Agilent Technologies, Inc.
Apogee Flow Systems Ltd.
Becton, Dickinson and Company
bioAffinity Technologies, Inc.
Bio-Rad Laboratories, Inc.
Bio-Techne Corporation Cytek Biosciences
Cytognos, S.L.
Danaher Corporation
Miltenyi Biotec B.V. and Co. KG
Laboratory Corporation of America Holdings
Luminex Corporation
NeoGenomics Laboratories, Inc.
Sony Corporation
Thermo Fisher Scientific Inc
Segment by Type
Assays and Kits
Instruments
Reagents and Consumables
Software
Segment by Application
Diagnostic Laboratories
Hospitals and Healthcare Centers
Academic and Research Institutions
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Flow Cytometry in Oncology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Flow Cytometry in Oncology Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Assays and Kits
1.2.3 Instruments
1.2.4 Reagents and Consumables
1.2.5 Software
1.3 Market by Application
1.3.1 Global Flow Cytometry in Oncology Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Diagnostic Laboratories
1.3.3 Hospitals and Healthcare Centers
1.3.4 Academic and Research Institutions
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Flow Cytometry in Oncology Market Perspective (2020-2031)
2.2 Global Flow Cytometry in Oncology Growth Trends by Region
2.2.1 Global Flow Cytometry in Oncology Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Flow Cytometry in Oncology Historic Market Size by Region (2020-2025)
2.2.3 Flow Cytometry in Oncology Forecasted Market Size by Region (2026-2031)
2.3 Flow Cytometry in Oncology Market Dynamics
2.3.1 Flow Cytometry in Oncology Industry Trends
2.3.2 Flow Cytometry in Oncology Market Drivers
2.3.3 Flow Cytometry in Oncology Market Challenges
2.3.4 Flow Cytometry in Oncology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Flow Cytometry in Oncology Players by Revenue
3.1.1 Global Top Flow Cytometry in Oncology Players by Revenue (2020-2025)
3.1.2 Global Flow Cytometry in Oncology Revenue Market Share by Players (2020-2025)
3.2 Global Flow Cytometry in Oncology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Flow Cytometry in Oncology Revenue
3.4 Global Flow Cytometry in Oncology Market Concentration Ratio
3.4.1 Global Flow Cytometry in Oncology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Flow Cytometry in Oncology Revenue in 2024
3.5 Global Key Players of Flow Cytometry in Oncology Head office and Area Served
3.6 Global Key Players of Flow Cytometry in Oncology, Product and Application
3.7 Global Key Players of Flow Cytometry in Oncology, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Flow Cytometry in Oncology Breakdown Data by Type
4.1 Global Flow Cytometry in Oncology Historic Market Size by Type (2020-2025)
4.2 Global Flow Cytometry in Oncology Forecasted Market Size by Type (2026-2031)
5 Flow Cytometry in Oncology Breakdown Data by Application
5.1 Global Flow Cytometry in Oncology Historic Market Size by Application (2020-2025)
5.2 Global Flow Cytometry in Oncology Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Flow Cytometry in Oncology Market Size (2020-2031)
6.2 North America Flow Cytometry in Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Flow Cytometry in Oncology Market Size by Country (2020-2025)
6.4 North America Flow Cytometry in Oncology Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Flow Cytometry in Oncology Market Size (2020-2031)
7.2 Europe Flow Cytometry in Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Flow Cytometry in Oncology Market Size by Country (2020-2025)
7.4 Europe Flow Cytometry in Oncology Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Flow Cytometry in Oncology Market Size (2020-2031)
8.2 Asia-Pacific Flow Cytometry in Oncology Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Flow Cytometry in Oncology Market Size by Region (2020-2025)
8.4 Asia-Pacific Flow Cytometry in Oncology Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Flow Cytometry in Oncology Market Size (2020-2031)
9.2 Latin America Flow Cytometry in Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Flow Cytometry in Oncology Market Size by Country (2020-2025)
9.4 Latin America Flow Cytometry in Oncology Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Flow Cytometry in Oncology Market Size (2020-2031)
10.2 Middle East & Africa Flow Cytometry in Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Flow Cytometry in Oncology Market Size by Country (2020-2025)
10.4 Middle East & Africa Flow Cytometry in Oncology Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Agilent Technologies, Inc.
11.1.1 Agilent Technologies, Inc. Company Details
11.1.2 Agilent Technologies, Inc. Business Overview
11.1.3 Agilent Technologies, Inc. Flow Cytometry in Oncology Introduction
11.1.4 Agilent Technologies, Inc. Revenue in Flow Cytometry in Oncology Business (2020-2025)
11.1.5 Agilent Technologies, Inc. Recent Development
11.2 Apogee Flow Systems Ltd.
11.2.1 Apogee Flow Systems Ltd. Company Details
11.2.2 Apogee Flow Systems Ltd. Business Overview
11.2.3 Apogee Flow Systems Ltd. Flow Cytometry in Oncology Introduction
11.2.4 Apogee Flow Systems Ltd. Revenue in Flow Cytometry in Oncology Business (2020-2025)
11.2.5 Apogee Flow Systems Ltd. Recent Development
11.3 Becton, Dickinson and Company
11.3.1 Becton, Dickinson and Company Company Details
11.3.2 Becton, Dickinson and Company Business Overview
11.3.3 Becton, Dickinson and Company Flow Cytometry in Oncology Introduction
11.3.4 Becton, Dickinson and Company Revenue in Flow Cytometry in Oncology Business (2020-2025)
11.3.5 Becton, Dickinson and Company Recent Development
11.4 bioAffinity Technologies, Inc.
11.4.1 bioAffinity Technologies, Inc. Company Details
11.4.2 bioAffinity Technologies, Inc. Business Overview
11.4.3 bioAffinity Technologies, Inc. Flow Cytometry in Oncology Introduction
11.4.4 bioAffinity Technologies, Inc. Revenue in Flow Cytometry in Oncology Business (2020-2025)
11.4.5 bioAffinity Technologies, Inc. Recent Development
11.5 Bio-Rad Laboratories, Inc.
11.5.1 Bio-Rad Laboratories, Inc. Company Details
11.5.2 Bio-Rad Laboratories, Inc. Business Overview
11.5.3 Bio-Rad Laboratories, Inc. Flow Cytometry in Oncology Introduction
11.5.4 Bio-Rad Laboratories, Inc. Revenue in Flow Cytometry in Oncology Business (2020-2025)
11.5.5 Bio-Rad Laboratories, Inc. Recent Development
11.6 Bio-Techne Corporation Cytek Biosciences
11.6.1 Bio-Techne Corporation Cytek Biosciences Company Details
11.6.2 Bio-Techne Corporation Cytek Biosciences Business Overview
11.6.3 Bio-Techne Corporation Cytek Biosciences Flow Cytometry in Oncology Introduction
11.6.4 Bio-Techne Corporation Cytek Biosciences Revenue in Flow Cytometry in Oncology Business (2020-2025)
11.6.5 Bio-Techne Corporation Cytek Biosciences Recent Development
11.7 Cytognos, S.L.
11.7.1 Cytognos, S.L. Company Details
11.7.2 Cytognos, S.L. Business Overview
11.7.3 Cytognos, S.L. Flow Cytometry in Oncology Introduction
11.7.4 Cytognos, S.L. Revenue in Flow Cytometry in Oncology Business (2020-2025)
11.7.5 Cytognos, S.L. Recent Development
11.8 Danaher Corporation
11.8.1 Danaher Corporation Company Details
11.8.2 Danaher Corporation Business Overview
11.8.3 Danaher Corporation Flow Cytometry in Oncology Introduction
11.8.4 Danaher Corporation Revenue in Flow Cytometry in Oncology Business (2020-2025)
11.8.5 Danaher Corporation Recent Development
11.9 Miltenyi Biotec B.V. and Co. KG
11.9.1 Miltenyi Biotec B.V. and Co. KG Company Details
11.9.2 Miltenyi Biotec B.V. and Co. KG Business Overview
11.9.3 Miltenyi Biotec B.V. and Co. KG Flow Cytometry in Oncology Introduction
11.9.4 Miltenyi Biotec B.V. and Co. KG Revenue in Flow Cytometry in Oncology Business (2020-2025)
11.9.5 Miltenyi Biotec B.V. and Co. KG Recent Development
11.10 Laboratory Corporation of America Holdings
11.10.1 Laboratory Corporation of America Holdings Company Details
11.10.2 Laboratory Corporation of America Holdings Business Overview
11.10.3 Laboratory Corporation of America Holdings Flow Cytometry in Oncology Introduction
11.10.4 Laboratory Corporation of America Holdings Revenue in Flow Cytometry in Oncology Business (2020-2025)
11.10.5 Laboratory Corporation of America Holdings Recent Development
11.11 Luminex Corporation
11.11.1 Luminex Corporation Company Details
11.11.2 Luminex Corporation Business Overview
11.11.3 Luminex Corporation Flow Cytometry in Oncology Introduction
11.11.4 Luminex Corporation Revenue in Flow Cytometry in Oncology Business (2020-2025)
11.11.5 Luminex Corporation Recent Development
11.12 NeoGenomics Laboratories, Inc.
11.12.1 NeoGenomics Laboratories, Inc. Company Details
11.12.2 NeoGenomics Laboratories, Inc. Business Overview
11.12.3 NeoGenomics Laboratories, Inc. Flow Cytometry in Oncology Introduction
11.12.4 NeoGenomics Laboratories, Inc. Revenue in Flow Cytometry in Oncology Business (2020-2025)
11.12.5 NeoGenomics Laboratories, Inc. Recent Development
11.13 Sony Corporation
11.13.1 Sony Corporation Company Details
11.13.2 Sony Corporation Business Overview
11.13.3 Sony Corporation Flow Cytometry in Oncology Introduction
11.13.4 Sony Corporation Revenue in Flow Cytometry in Oncology Business (2020-2025)
11.13.5 Sony Corporation Recent Development
11.14 Thermo Fisher Scientific Inc
11.14.1 Thermo Fisher Scientific Inc Company Details
11.14.2 Thermo Fisher Scientific Inc Business Overview
11.14.3 Thermo Fisher Scientific Inc Flow Cytometry in Oncology Introduction
11.14.4 Thermo Fisher Scientific Inc Revenue in Flow Cytometry in Oncology Business (2020-2025)
11.14.5 Thermo Fisher Scientific Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Flow Cytometry in Oncology Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Assays and Kits
1.2.3 Instruments
1.2.4 Reagents and Consumables
1.2.5 Software
1.3 Market by Application
1.3.1 Global Flow Cytometry in Oncology Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Diagnostic Laboratories
1.3.3 Hospitals and Healthcare Centers
1.3.4 Academic and Research Institutions
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Flow Cytometry in Oncology Market Perspective (2020-2031)
2.2 Global Flow Cytometry in Oncology Growth Trends by Region
2.2.1 Global Flow Cytometry in Oncology Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Flow Cytometry in Oncology Historic Market Size by Region (2020-2025)
2.2.3 Flow Cytometry in Oncology Forecasted Market Size by Region (2026-2031)
2.3 Flow Cytometry in Oncology Market Dynamics
2.3.1 Flow Cytometry in Oncology Industry Trends
2.3.2 Flow Cytometry in Oncology Market Drivers
2.3.3 Flow Cytometry in Oncology Market Challenges
2.3.4 Flow Cytometry in Oncology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Flow Cytometry in Oncology Players by Revenue
3.1.1 Global Top Flow Cytometry in Oncology Players by Revenue (2020-2025)
3.1.2 Global Flow Cytometry in Oncology Revenue Market Share by Players (2020-2025)
3.2 Global Flow Cytometry in Oncology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Flow Cytometry in Oncology Revenue
3.4 Global Flow Cytometry in Oncology Market Concentration Ratio
3.4.1 Global Flow Cytometry in Oncology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Flow Cytometry in Oncology Revenue in 2024
3.5 Global Key Players of Flow Cytometry in Oncology Head office and Area Served
3.6 Global Key Players of Flow Cytometry in Oncology, Product and Application
3.7 Global Key Players of Flow Cytometry in Oncology, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Flow Cytometry in Oncology Breakdown Data by Type
4.1 Global Flow Cytometry in Oncology Historic Market Size by Type (2020-2025)
4.2 Global Flow Cytometry in Oncology Forecasted Market Size by Type (2026-2031)
5 Flow Cytometry in Oncology Breakdown Data by Application
5.1 Global Flow Cytometry in Oncology Historic Market Size by Application (2020-2025)
5.2 Global Flow Cytometry in Oncology Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Flow Cytometry in Oncology Market Size (2020-2031)
6.2 North America Flow Cytometry in Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Flow Cytometry in Oncology Market Size by Country (2020-2025)
6.4 North America Flow Cytometry in Oncology Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Flow Cytometry in Oncology Market Size (2020-2031)
7.2 Europe Flow Cytometry in Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Flow Cytometry in Oncology Market Size by Country (2020-2025)
7.4 Europe Flow Cytometry in Oncology Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Flow Cytometry in Oncology Market Size (2020-2031)
8.2 Asia-Pacific Flow Cytometry in Oncology Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Flow Cytometry in Oncology Market Size by Region (2020-2025)
8.4 Asia-Pacific Flow Cytometry in Oncology Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Flow Cytometry in Oncology Market Size (2020-2031)
9.2 Latin America Flow Cytometry in Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Flow Cytometry in Oncology Market Size by Country (2020-2025)
9.4 Latin America Flow Cytometry in Oncology Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Flow Cytometry in Oncology Market Size (2020-2031)
10.2 Middle East & Africa Flow Cytometry in Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Flow Cytometry in Oncology Market Size by Country (2020-2025)
10.4 Middle East & Africa Flow Cytometry in Oncology Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Agilent Technologies, Inc.
11.1.1 Agilent Technologies, Inc. Company Details
11.1.2 Agilent Technologies, Inc. Business Overview
11.1.3 Agilent Technologies, Inc. Flow Cytometry in Oncology Introduction
11.1.4 Agilent Technologies, Inc. Revenue in Flow Cytometry in Oncology Business (2020-2025)
11.1.5 Agilent Technologies, Inc. Recent Development
11.2 Apogee Flow Systems Ltd.
11.2.1 Apogee Flow Systems Ltd. Company Details
11.2.2 Apogee Flow Systems Ltd. Business Overview
11.2.3 Apogee Flow Systems Ltd. Flow Cytometry in Oncology Introduction
11.2.4 Apogee Flow Systems Ltd. Revenue in Flow Cytometry in Oncology Business (2020-2025)
11.2.5 Apogee Flow Systems Ltd. Recent Development
11.3 Becton, Dickinson and Company
11.3.1 Becton, Dickinson and Company Company Details
11.3.2 Becton, Dickinson and Company Business Overview
11.3.3 Becton, Dickinson and Company Flow Cytometry in Oncology Introduction
11.3.4 Becton, Dickinson and Company Revenue in Flow Cytometry in Oncology Business (2020-2025)
11.3.5 Becton, Dickinson and Company Recent Development
11.4 bioAffinity Technologies, Inc.
11.4.1 bioAffinity Technologies, Inc. Company Details
11.4.2 bioAffinity Technologies, Inc. Business Overview
11.4.3 bioAffinity Technologies, Inc. Flow Cytometry in Oncology Introduction
11.4.4 bioAffinity Technologies, Inc. Revenue in Flow Cytometry in Oncology Business (2020-2025)
11.4.5 bioAffinity Technologies, Inc. Recent Development
11.5 Bio-Rad Laboratories, Inc.
11.5.1 Bio-Rad Laboratories, Inc. Company Details
11.5.2 Bio-Rad Laboratories, Inc. Business Overview
11.5.3 Bio-Rad Laboratories, Inc. Flow Cytometry in Oncology Introduction
11.5.4 Bio-Rad Laboratories, Inc. Revenue in Flow Cytometry in Oncology Business (2020-2025)
11.5.5 Bio-Rad Laboratories, Inc. Recent Development
11.6 Bio-Techne Corporation Cytek Biosciences
11.6.1 Bio-Techne Corporation Cytek Biosciences Company Details
11.6.2 Bio-Techne Corporation Cytek Biosciences Business Overview
11.6.3 Bio-Techne Corporation Cytek Biosciences Flow Cytometry in Oncology Introduction
11.6.4 Bio-Techne Corporation Cytek Biosciences Revenue in Flow Cytometry in Oncology Business (2020-2025)
11.6.5 Bio-Techne Corporation Cytek Biosciences Recent Development
11.7 Cytognos, S.L.
11.7.1 Cytognos, S.L. Company Details
11.7.2 Cytognos, S.L. Business Overview
11.7.3 Cytognos, S.L. Flow Cytometry in Oncology Introduction
11.7.4 Cytognos, S.L. Revenue in Flow Cytometry in Oncology Business (2020-2025)
11.7.5 Cytognos, S.L. Recent Development
11.8 Danaher Corporation
11.8.1 Danaher Corporation Company Details
11.8.2 Danaher Corporation Business Overview
11.8.3 Danaher Corporation Flow Cytometry in Oncology Introduction
11.8.4 Danaher Corporation Revenue in Flow Cytometry in Oncology Business (2020-2025)
11.8.5 Danaher Corporation Recent Development
11.9 Miltenyi Biotec B.V. and Co. KG
11.9.1 Miltenyi Biotec B.V. and Co. KG Company Details
11.9.2 Miltenyi Biotec B.V. and Co. KG Business Overview
11.9.3 Miltenyi Biotec B.V. and Co. KG Flow Cytometry in Oncology Introduction
11.9.4 Miltenyi Biotec B.V. and Co. KG Revenue in Flow Cytometry in Oncology Business (2020-2025)
11.9.5 Miltenyi Biotec B.V. and Co. KG Recent Development
11.10 Laboratory Corporation of America Holdings
11.10.1 Laboratory Corporation of America Holdings Company Details
11.10.2 Laboratory Corporation of America Holdings Business Overview
11.10.3 Laboratory Corporation of America Holdings Flow Cytometry in Oncology Introduction
11.10.4 Laboratory Corporation of America Holdings Revenue in Flow Cytometry in Oncology Business (2020-2025)
11.10.5 Laboratory Corporation of America Holdings Recent Development
11.11 Luminex Corporation
11.11.1 Luminex Corporation Company Details
11.11.2 Luminex Corporation Business Overview
11.11.3 Luminex Corporation Flow Cytometry in Oncology Introduction
11.11.4 Luminex Corporation Revenue in Flow Cytometry in Oncology Business (2020-2025)
11.11.5 Luminex Corporation Recent Development
11.12 NeoGenomics Laboratories, Inc.
11.12.1 NeoGenomics Laboratories, Inc. Company Details
11.12.2 NeoGenomics Laboratories, Inc. Business Overview
11.12.3 NeoGenomics Laboratories, Inc. Flow Cytometry in Oncology Introduction
11.12.4 NeoGenomics Laboratories, Inc. Revenue in Flow Cytometry in Oncology Business (2020-2025)
11.12.5 NeoGenomics Laboratories, Inc. Recent Development
11.13 Sony Corporation
11.13.1 Sony Corporation Company Details
11.13.2 Sony Corporation Business Overview
11.13.3 Sony Corporation Flow Cytometry in Oncology Introduction
11.13.4 Sony Corporation Revenue in Flow Cytometry in Oncology Business (2020-2025)
11.13.5 Sony Corporation Recent Development
11.14 Thermo Fisher Scientific Inc
11.14.1 Thermo Fisher Scientific Inc Company Details
11.14.2 Thermo Fisher Scientific Inc Business Overview
11.14.3 Thermo Fisher Scientific Inc Flow Cytometry in Oncology Introduction
11.14.4 Thermo Fisher Scientific Inc Revenue in Flow Cytometry in Oncology Business (2020-2025)
11.14.5 Thermo Fisher Scientific Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Flow Cytometry in Oncology Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Assays and Kits
Table 3. Key Players of Instruments
Table 4. Key Players of Reagents and Consumables
Table 5. Key Players of Software
Table 6. Global Flow Cytometry in Oncology Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Flow Cytometry in Oncology Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Flow Cytometry in Oncology Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Flow Cytometry in Oncology Market Share by Region (2020-2025)
Table 10. Global Flow Cytometry in Oncology Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Flow Cytometry in Oncology Market Share by Region (2026-2031)
Table 12. Flow Cytometry in Oncology Market Trends
Table 13. Flow Cytometry in Oncology Market Drivers
Table 14. Flow Cytometry in Oncology Market Challenges
Table 15. Flow Cytometry in Oncology Market Restraints
Table 16. Global Flow Cytometry in Oncology Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Flow Cytometry in Oncology Market Share by Players (2020-2025)
Table 18. Global Top Flow Cytometry in Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Flow Cytometry in Oncology as of 2024)
Table 19. Ranking of Global Top Flow Cytometry in Oncology Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Flow Cytometry in Oncology Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Flow Cytometry in Oncology, Headquarters and Area Served
Table 22. Global Key Players of Flow Cytometry in Oncology, Product and Application
Table 23. Global Key Players of Flow Cytometry in Oncology, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Flow Cytometry in Oncology Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Flow Cytometry in Oncology Revenue Market Share by Type (2020-2025)
Table 27. Global Flow Cytometry in Oncology Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Flow Cytometry in Oncology Revenue Market Share by Type (2026-2031)
Table 29. Global Flow Cytometry in Oncology Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Flow Cytometry in Oncology Revenue Market Share by Application (2020-2025)
Table 31. Global Flow Cytometry in Oncology Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Flow Cytometry in Oncology Revenue Market Share by Application (2026-2031)
Table 33. North America Flow Cytometry in Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Flow Cytometry in Oncology Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Flow Cytometry in Oncology Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Flow Cytometry in Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Flow Cytometry in Oncology Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Flow Cytometry in Oncology Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Flow Cytometry in Oncology Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Flow Cytometry in Oncology Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Flow Cytometry in Oncology Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Flow Cytometry in Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Flow Cytometry in Oncology Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Flow Cytometry in Oncology Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Flow Cytometry in Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Flow Cytometry in Oncology Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Flow Cytometry in Oncology Market Size by Country (2026-2031) & (US$ Million)
Table 48. Agilent Technologies, Inc. Company Details
Table 49. Agilent Technologies, Inc. Business Overview
Table 50. Agilent Technologies, Inc. Flow Cytometry in Oncology Product
Table 51. Agilent Technologies, Inc. Revenue in Flow Cytometry in Oncology Business (2020-2025) & (US$ Million)
Table 52. Agilent Technologies, Inc. Recent Development
Table 53. Apogee Flow Systems Ltd. Company Details
Table 54. Apogee Flow Systems Ltd. Business Overview
Table 55. Apogee Flow Systems Ltd. Flow Cytometry in Oncology Product
Table 56. Apogee Flow Systems Ltd. Revenue in Flow Cytometry in Oncology Business (2020-2025) & (US$ Million)
Table 57. Apogee Flow Systems Ltd. Recent Development
Table 58. Becton, Dickinson and Company Company Details
Table 59. Becton, Dickinson and Company Business Overview
Table 60. Becton, Dickinson and Company Flow Cytometry in Oncology Product
Table 61. Becton, Dickinson and Company Revenue in Flow Cytometry in Oncology Business (2020-2025) & (US$ Million)
Table 62. Becton, Dickinson and Company Recent Development
Table 63. bioAffinity Technologies, Inc. Company Details
Table 64. bioAffinity Technologies, Inc. Business Overview
Table 65. bioAffinity Technologies, Inc. Flow Cytometry in Oncology Product
Table 66. bioAffinity Technologies, Inc. Revenue in Flow Cytometry in Oncology Business (2020-2025) & (US$ Million)
Table 67. bioAffinity Technologies, Inc. Recent Development
Table 68. Bio-Rad Laboratories, Inc. Company Details
Table 69. Bio-Rad Laboratories, Inc. Business Overview
Table 70. Bio-Rad Laboratories, Inc. Flow Cytometry in Oncology Product
Table 71. Bio-Rad Laboratories, Inc. Revenue in Flow Cytometry in Oncology Business (2020-2025) & (US$ Million)
Table 72. Bio-Rad Laboratories, Inc. Recent Development
Table 73. Bio-Techne Corporation Cytek Biosciences Company Details
Table 74. Bio-Techne Corporation Cytek Biosciences Business Overview
Table 75. Bio-Techne Corporation Cytek Biosciences Flow Cytometry in Oncology Product
Table 76. Bio-Techne Corporation Cytek Biosciences Revenue in Flow Cytometry in Oncology Business (2020-2025) & (US$ Million)
Table 77. Bio-Techne Corporation Cytek Biosciences Recent Development
Table 78. Cytognos, S.L. Company Details
Table 79. Cytognos, S.L. Business Overview
Table 80. Cytognos, S.L. Flow Cytometry in Oncology Product
Table 81. Cytognos, S.L. Revenue in Flow Cytometry in Oncology Business (2020-2025) & (US$ Million)
Table 82. Cytognos, S.L. Recent Development
Table 83. Danaher Corporation Company Details
Table 84. Danaher Corporation Business Overview
Table 85. Danaher Corporation Flow Cytometry in Oncology Product
Table 86. Danaher Corporation Revenue in Flow Cytometry in Oncology Business (2020-2025) & (US$ Million)
Table 87. Danaher Corporation Recent Development
Table 88. Miltenyi Biotec B.V. and Co. KG Company Details
Table 89. Miltenyi Biotec B.V. and Co. KG Business Overview
Table 90. Miltenyi Biotec B.V. and Co. KG Flow Cytometry in Oncology Product
Table 91. Miltenyi Biotec B.V. and Co. KG Revenue in Flow Cytometry in Oncology Business (2020-2025) & (US$ Million)
Table 92. Miltenyi Biotec B.V. and Co. KG Recent Development
Table 93. Laboratory Corporation of America Holdings Company Details
Table 94. Laboratory Corporation of America Holdings Business Overview
Table 95. Laboratory Corporation of America Holdings Flow Cytometry in Oncology Product
Table 96. Laboratory Corporation of America Holdings Revenue in Flow Cytometry in Oncology Business (2020-2025) & (US$ Million)
Table 97. Laboratory Corporation of America Holdings Recent Development
Table 98. Luminex Corporation Company Details
Table 99. Luminex Corporation Business Overview
Table 100. Luminex Corporation Flow Cytometry in Oncology Product
Table 101. Luminex Corporation Revenue in Flow Cytometry in Oncology Business (2020-2025) & (US$ Million)
Table 102. Luminex Corporation Recent Development
Table 103. NeoGenomics Laboratories, Inc. Company Details
Table 104. NeoGenomics Laboratories, Inc. Business Overview
Table 105. NeoGenomics Laboratories, Inc. Flow Cytometry in Oncology Product
Table 106. NeoGenomics Laboratories, Inc. Revenue in Flow Cytometry in Oncology Business (2020-2025) & (US$ Million)
Table 107. NeoGenomics Laboratories, Inc. Recent Development
Table 108. Sony Corporation Company Details
Table 109. Sony Corporation Business Overview
Table 110. Sony Corporation Flow Cytometry in Oncology Product
Table 111. Sony Corporation Revenue in Flow Cytometry in Oncology Business (2020-2025) & (US$ Million)
Table 112. Sony Corporation Recent Development
Table 113. Thermo Fisher Scientific Inc Company Details
Table 114. Thermo Fisher Scientific Inc Business Overview
Table 115. Thermo Fisher Scientific Inc Flow Cytometry in Oncology Product
Table 116. Thermo Fisher Scientific Inc Revenue in Flow Cytometry in Oncology Business (2020-2025) & (US$ Million)
Table 117. Thermo Fisher Scientific Inc Recent Development
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report
List of Figures
Figure 1. Flow Cytometry in Oncology Picture
Figure 2. Global Flow Cytometry in Oncology Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Flow Cytometry in Oncology Market Share by Type: 2024 VS 2031
Figure 4. Assays and Kits Features
Figure 5. Instruments Features
Figure 6. Reagents and Consumables Features
Figure 7. Software Features
Figure 8. Global Flow Cytometry in Oncology Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Flow Cytometry in Oncology Market Share by Application: 2024 VS 2031
Figure 10. Diagnostic Laboratories Case Studies
Figure 11. Hospitals and Healthcare Centers Case Studies
Figure 12. Academic and Research Institutions Case Studies
Figure 13. Others Case Studies
Figure 14. Flow Cytometry in Oncology Report Years Considered
Figure 15. Global Flow Cytometry in Oncology Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Flow Cytometry in Oncology Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Flow Cytometry in Oncology Market Share by Region: 2024 VS 2031
Figure 18. Global Flow Cytometry in Oncology Market Share by Players in 2024
Figure 19. Global Top Flow Cytometry in Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Flow Cytometry in Oncology as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Flow Cytometry in Oncology Revenue in 2024
Figure 21. North America Flow Cytometry in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Flow Cytometry in Oncology Market Share by Country (2020-2031)
Figure 23. United States Flow Cytometry in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Flow Cytometry in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Flow Cytometry in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Flow Cytometry in Oncology Market Share by Country (2020-2031)
Figure 27. Germany Flow Cytometry in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Flow Cytometry in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Flow Cytometry in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Flow Cytometry in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Flow Cytometry in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Flow Cytometry in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Flow Cytometry in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Flow Cytometry in Oncology Market Share by Region (2020-2031)
Figure 35. China Flow Cytometry in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Flow Cytometry in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Flow Cytometry in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Flow Cytometry in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Flow Cytometry in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Flow Cytometry in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Flow Cytometry in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Flow Cytometry in Oncology Market Share by Country (2020-2031)
Figure 43. Mexico Flow Cytometry in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Flow Cytometry in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Flow Cytometry in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Flow Cytometry in Oncology Market Share by Country (2020-2031)
Figure 47. Turkey Flow Cytometry in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Flow Cytometry in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Flow Cytometry in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Agilent Technologies, Inc. Revenue Growth Rate in Flow Cytometry in Oncology Business (2020-2025)
Figure 51. Apogee Flow Systems Ltd. Revenue Growth Rate in Flow Cytometry in Oncology Business (2020-2025)
Figure 52. Becton, Dickinson and Company Revenue Growth Rate in Flow Cytometry in Oncology Business (2020-2025)
Figure 53. bioAffinity Technologies, Inc. Revenue Growth Rate in Flow Cytometry in Oncology Business (2020-2025)
Figure 54. Bio-Rad Laboratories, Inc. Revenue Growth Rate in Flow Cytometry in Oncology Business (2020-2025)
Figure 55. Bio-Techne Corporation Cytek Biosciences Revenue Growth Rate in Flow Cytometry in Oncology Business (2020-2025)
Figure 56. Cytognos, S.L. Revenue Growth Rate in Flow Cytometry in Oncology Business (2020-2025)
Figure 57. Danaher Corporation Revenue Growth Rate in Flow Cytometry in Oncology Business (2020-2025)
Figure 58. Miltenyi Biotec B.V. and Co. KG Revenue Growth Rate in Flow Cytometry in Oncology Business (2020-2025)
Figure 59. Laboratory Corporation of America Holdings Revenue Growth Rate in Flow Cytometry in Oncology Business (2020-2025)
Figure 60. Luminex Corporation Revenue Growth Rate in Flow Cytometry in Oncology Business (2020-2025)
Figure 61. NeoGenomics Laboratories, Inc. Revenue Growth Rate in Flow Cytometry in Oncology Business (2020-2025)
Figure 62. Sony Corporation Revenue Growth Rate in Flow Cytometry in Oncology Business (2020-2025)
Figure 63. Thermo Fisher Scientific Inc Revenue Growth Rate in Flow Cytometry in Oncology Business (2020-2025)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Table 1. Global Flow Cytometry in Oncology Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Assays and Kits
Table 3. Key Players of Instruments
Table 4. Key Players of Reagents and Consumables
Table 5. Key Players of Software
Table 6. Global Flow Cytometry in Oncology Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Flow Cytometry in Oncology Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Flow Cytometry in Oncology Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Flow Cytometry in Oncology Market Share by Region (2020-2025)
Table 10. Global Flow Cytometry in Oncology Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Flow Cytometry in Oncology Market Share by Region (2026-2031)
Table 12. Flow Cytometry in Oncology Market Trends
Table 13. Flow Cytometry in Oncology Market Drivers
Table 14. Flow Cytometry in Oncology Market Challenges
Table 15. Flow Cytometry in Oncology Market Restraints
Table 16. Global Flow Cytometry in Oncology Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Flow Cytometry in Oncology Market Share by Players (2020-2025)
Table 18. Global Top Flow Cytometry in Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Flow Cytometry in Oncology as of 2024)
Table 19. Ranking of Global Top Flow Cytometry in Oncology Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Flow Cytometry in Oncology Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Flow Cytometry in Oncology, Headquarters and Area Served
Table 22. Global Key Players of Flow Cytometry in Oncology, Product and Application
Table 23. Global Key Players of Flow Cytometry in Oncology, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Flow Cytometry in Oncology Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Flow Cytometry in Oncology Revenue Market Share by Type (2020-2025)
Table 27. Global Flow Cytometry in Oncology Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Flow Cytometry in Oncology Revenue Market Share by Type (2026-2031)
Table 29. Global Flow Cytometry in Oncology Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Flow Cytometry in Oncology Revenue Market Share by Application (2020-2025)
Table 31. Global Flow Cytometry in Oncology Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Flow Cytometry in Oncology Revenue Market Share by Application (2026-2031)
Table 33. North America Flow Cytometry in Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Flow Cytometry in Oncology Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Flow Cytometry in Oncology Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Flow Cytometry in Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Flow Cytometry in Oncology Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Flow Cytometry in Oncology Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Flow Cytometry in Oncology Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Flow Cytometry in Oncology Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Flow Cytometry in Oncology Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Flow Cytometry in Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Flow Cytometry in Oncology Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Flow Cytometry in Oncology Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Flow Cytometry in Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Flow Cytometry in Oncology Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Flow Cytometry in Oncology Market Size by Country (2026-2031) & (US$ Million)
Table 48. Agilent Technologies, Inc. Company Details
Table 49. Agilent Technologies, Inc. Business Overview
Table 50. Agilent Technologies, Inc. Flow Cytometry in Oncology Product
Table 51. Agilent Technologies, Inc. Revenue in Flow Cytometry in Oncology Business (2020-2025) & (US$ Million)
Table 52. Agilent Technologies, Inc. Recent Development
Table 53. Apogee Flow Systems Ltd. Company Details
Table 54. Apogee Flow Systems Ltd. Business Overview
Table 55. Apogee Flow Systems Ltd. Flow Cytometry in Oncology Product
Table 56. Apogee Flow Systems Ltd. Revenue in Flow Cytometry in Oncology Business (2020-2025) & (US$ Million)
Table 57. Apogee Flow Systems Ltd. Recent Development
Table 58. Becton, Dickinson and Company Company Details
Table 59. Becton, Dickinson and Company Business Overview
Table 60. Becton, Dickinson and Company Flow Cytometry in Oncology Product
Table 61. Becton, Dickinson and Company Revenue in Flow Cytometry in Oncology Business (2020-2025) & (US$ Million)
Table 62. Becton, Dickinson and Company Recent Development
Table 63. bioAffinity Technologies, Inc. Company Details
Table 64. bioAffinity Technologies, Inc. Business Overview
Table 65. bioAffinity Technologies, Inc. Flow Cytometry in Oncology Product
Table 66. bioAffinity Technologies, Inc. Revenue in Flow Cytometry in Oncology Business (2020-2025) & (US$ Million)
Table 67. bioAffinity Technologies, Inc. Recent Development
Table 68. Bio-Rad Laboratories, Inc. Company Details
Table 69. Bio-Rad Laboratories, Inc. Business Overview
Table 70. Bio-Rad Laboratories, Inc. Flow Cytometry in Oncology Product
Table 71. Bio-Rad Laboratories, Inc. Revenue in Flow Cytometry in Oncology Business (2020-2025) & (US$ Million)
Table 72. Bio-Rad Laboratories, Inc. Recent Development
Table 73. Bio-Techne Corporation Cytek Biosciences Company Details
Table 74. Bio-Techne Corporation Cytek Biosciences Business Overview
Table 75. Bio-Techne Corporation Cytek Biosciences Flow Cytometry in Oncology Product
Table 76. Bio-Techne Corporation Cytek Biosciences Revenue in Flow Cytometry in Oncology Business (2020-2025) & (US$ Million)
Table 77. Bio-Techne Corporation Cytek Biosciences Recent Development
Table 78. Cytognos, S.L. Company Details
Table 79. Cytognos, S.L. Business Overview
Table 80. Cytognos, S.L. Flow Cytometry in Oncology Product
Table 81. Cytognos, S.L. Revenue in Flow Cytometry in Oncology Business (2020-2025) & (US$ Million)
Table 82. Cytognos, S.L. Recent Development
Table 83. Danaher Corporation Company Details
Table 84. Danaher Corporation Business Overview
Table 85. Danaher Corporation Flow Cytometry in Oncology Product
Table 86. Danaher Corporation Revenue in Flow Cytometry in Oncology Business (2020-2025) & (US$ Million)
Table 87. Danaher Corporation Recent Development
Table 88. Miltenyi Biotec B.V. and Co. KG Company Details
Table 89. Miltenyi Biotec B.V. and Co. KG Business Overview
Table 90. Miltenyi Biotec B.V. and Co. KG Flow Cytometry in Oncology Product
Table 91. Miltenyi Biotec B.V. and Co. KG Revenue in Flow Cytometry in Oncology Business (2020-2025) & (US$ Million)
Table 92. Miltenyi Biotec B.V. and Co. KG Recent Development
Table 93. Laboratory Corporation of America Holdings Company Details
Table 94. Laboratory Corporation of America Holdings Business Overview
Table 95. Laboratory Corporation of America Holdings Flow Cytometry in Oncology Product
Table 96. Laboratory Corporation of America Holdings Revenue in Flow Cytometry in Oncology Business (2020-2025) & (US$ Million)
Table 97. Laboratory Corporation of America Holdings Recent Development
Table 98. Luminex Corporation Company Details
Table 99. Luminex Corporation Business Overview
Table 100. Luminex Corporation Flow Cytometry in Oncology Product
Table 101. Luminex Corporation Revenue in Flow Cytometry in Oncology Business (2020-2025) & (US$ Million)
Table 102. Luminex Corporation Recent Development
Table 103. NeoGenomics Laboratories, Inc. Company Details
Table 104. NeoGenomics Laboratories, Inc. Business Overview
Table 105. NeoGenomics Laboratories, Inc. Flow Cytometry in Oncology Product
Table 106. NeoGenomics Laboratories, Inc. Revenue in Flow Cytometry in Oncology Business (2020-2025) & (US$ Million)
Table 107. NeoGenomics Laboratories, Inc. Recent Development
Table 108. Sony Corporation Company Details
Table 109. Sony Corporation Business Overview
Table 110. Sony Corporation Flow Cytometry in Oncology Product
Table 111. Sony Corporation Revenue in Flow Cytometry in Oncology Business (2020-2025) & (US$ Million)
Table 112. Sony Corporation Recent Development
Table 113. Thermo Fisher Scientific Inc Company Details
Table 114. Thermo Fisher Scientific Inc Business Overview
Table 115. Thermo Fisher Scientific Inc Flow Cytometry in Oncology Product
Table 116. Thermo Fisher Scientific Inc Revenue in Flow Cytometry in Oncology Business (2020-2025) & (US$ Million)
Table 117. Thermo Fisher Scientific Inc Recent Development
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report
List of Figures
Figure 1. Flow Cytometry in Oncology Picture
Figure 2. Global Flow Cytometry in Oncology Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Flow Cytometry in Oncology Market Share by Type: 2024 VS 2031
Figure 4. Assays and Kits Features
Figure 5. Instruments Features
Figure 6. Reagents and Consumables Features
Figure 7. Software Features
Figure 8. Global Flow Cytometry in Oncology Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Flow Cytometry in Oncology Market Share by Application: 2024 VS 2031
Figure 10. Diagnostic Laboratories Case Studies
Figure 11. Hospitals and Healthcare Centers Case Studies
Figure 12. Academic and Research Institutions Case Studies
Figure 13. Others Case Studies
Figure 14. Flow Cytometry in Oncology Report Years Considered
Figure 15. Global Flow Cytometry in Oncology Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Flow Cytometry in Oncology Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Flow Cytometry in Oncology Market Share by Region: 2024 VS 2031
Figure 18. Global Flow Cytometry in Oncology Market Share by Players in 2024
Figure 19. Global Top Flow Cytometry in Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Flow Cytometry in Oncology as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Flow Cytometry in Oncology Revenue in 2024
Figure 21. North America Flow Cytometry in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Flow Cytometry in Oncology Market Share by Country (2020-2031)
Figure 23. United States Flow Cytometry in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Flow Cytometry in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Flow Cytometry in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Flow Cytometry in Oncology Market Share by Country (2020-2031)
Figure 27. Germany Flow Cytometry in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Flow Cytometry in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Flow Cytometry in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Flow Cytometry in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Flow Cytometry in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Flow Cytometry in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Flow Cytometry in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Flow Cytometry in Oncology Market Share by Region (2020-2031)
Figure 35. China Flow Cytometry in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Flow Cytometry in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Flow Cytometry in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Flow Cytometry in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Flow Cytometry in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Flow Cytometry in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Flow Cytometry in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Flow Cytometry in Oncology Market Share by Country (2020-2031)
Figure 43. Mexico Flow Cytometry in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Flow Cytometry in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Flow Cytometry in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Flow Cytometry in Oncology Market Share by Country (2020-2031)
Figure 47. Turkey Flow Cytometry in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Flow Cytometry in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Flow Cytometry in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Agilent Technologies, Inc. Revenue Growth Rate in Flow Cytometry in Oncology Business (2020-2025)
Figure 51. Apogee Flow Systems Ltd. Revenue Growth Rate in Flow Cytometry in Oncology Business (2020-2025)
Figure 52. Becton, Dickinson and Company Revenue Growth Rate in Flow Cytometry in Oncology Business (2020-2025)
Figure 53. bioAffinity Technologies, Inc. Revenue Growth Rate in Flow Cytometry in Oncology Business (2020-2025)
Figure 54. Bio-Rad Laboratories, Inc. Revenue Growth Rate in Flow Cytometry in Oncology Business (2020-2025)
Figure 55. Bio-Techne Corporation Cytek Biosciences Revenue Growth Rate in Flow Cytometry in Oncology Business (2020-2025)
Figure 56. Cytognos, S.L. Revenue Growth Rate in Flow Cytometry in Oncology Business (2020-2025)
Figure 57. Danaher Corporation Revenue Growth Rate in Flow Cytometry in Oncology Business (2020-2025)
Figure 58. Miltenyi Biotec B.V. and Co. KG Revenue Growth Rate in Flow Cytometry in Oncology Business (2020-2025)
Figure 59. Laboratory Corporation of America Holdings Revenue Growth Rate in Flow Cytometry in Oncology Business (2020-2025)
Figure 60. Luminex Corporation Revenue Growth Rate in Flow Cytometry in Oncology Business (2020-2025)
Figure 61. NeoGenomics Laboratories, Inc. Revenue Growth Rate in Flow Cytometry in Oncology Business (2020-2025)
Figure 62. Sony Corporation Revenue Growth Rate in Flow Cytometry in Oncology Business (2020-2025)
Figure 63. Thermo Fisher Scientific Inc Revenue Growth Rate in Flow Cytometry in Oncology Business (2020-2025)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global White Oil Market Research Report 2025
Aug 11, 25
Global Piezo Materials Market Research Report 2025
Aug 11, 25
Global Piezoceramic Materials Market Research Report 2025
Aug 11, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232